Dr Vanessa Raymont
Dr Raymont is a senior clinical researcher and an honorary consultant old age psychiatrist.
Her personal clinical and research interests are in traumatic brain injury and memory disorders, as well as clinical trials in cognitive impairment, having had over 25 years of clinical and clinical research experience in both the UK and US. She was previously a clinical trials unit director in West London and has acted as principal investigator and chief investigator in over 20 clinical trials.
Dr Raymont is currently the Principal Investigator for the Oxford site of the EPAD (European Prevention of Alzheimer’s Dementia) longitudinal cohort study, New Therapeutics in Alzheimer’s Disease (NTAD), Brains for Dementia Research (BDR) and 7 Tesla MRI Scanning in Alzheimer’s disease and Frontotemporal Lobar Degeneration studies and Chief Investigator on the Deep and Frequent Phenotyping (DFP) and MIcroglial CSF1R in Alzheimer’s Disease (MICAD) studies. She is co-lead for the Clinical Trials section of Oxford Translational Neuroscience and Dementia Research Group and NIHR Dementia and Mental Health Lead for the Thames Valley and South Midlands Clinical Research Network. Dr Raymont is also an associate director of Dementia Platforms UK, and workstream lead for the Trials Delivery Framework.